Inflammatory and antioxidant pathway proteins

The term "Inflammatory and antioxidant pathway proteins" refers to a broad and non-specific group of molecular entities rather than a single, identifiable therapeutic target. These pathways involve a complex network of proteins that regulate the body's response to oxidative stress and inflammatory stimuli, such as the transcription factors Nuclear factor erythroid 2-related factor 2 (Nrf2) and Nuclear factor-kappa B (NF-κB) (NIH, 2023; PubMed, 2022). Nrf2 is a master regulator of the antioxidant response, while NF-κB is a central mediator of pro-inflammatory gene expression. Because this designation encompasses a wide variety of proteins with distinct structures and functions, it does not allow for the identification of specific interacting drugs or precise mechanisms of action. In a pharmacological context, this entry is considered incorrect or insufficient because it lacks the molecular specificity required for drug discovery, clinical targeting, or safety assessment (UniProt, 2024). Consequently, it should be replaced with specific protein names to be useful for structured data analysis.

Other names

Antioxidant response elementsInflammatory signaling proteinsOxidative stress response proteins

Not applicable for a generic pathway description.